Medical Health & Life Science Research News

Drug induced pruritus drives the pruritus therapeutic market in the coming years illuminated by new report

Medical Market Research

New product launches is a potential growth factor for Pruritus Therapeutic Market during the forecast period.

According to MarketIntelReports' “Global Pruritus Therapeutic Market 2017-2021”:

Browse 81 Pages and an in-depth TOC on “Pruritus Therapeutic Market 2017-2021 ” here…c-market-20172021 Make an Inquiry about this news

Pruritus can be described as an itching condition which can be unpleasant. It is due to dermatological disease conditions like dermatitis, chickenpox, atopic dermatitis, mycoses.

Diagnosing Pruritis needs a clinical examination and laboratory investigations which may be systemic, psychogenic, or neurogenic in nature. Chronic renal failure is the main cause for Pruritus.

Atopic dermatitis, urticaria, and allergic contact dermatitis enhance the Pruritus Therapeutic Market growth in the forecast period. A recent trend observed in the market is the application of novel technology for development of products to treat itching and rashes.

The growing number of patent expiry drugs creates new opportunities for the industry.

Scope & Regional Forecast of the Pruritus Therapeutic Market

Drug induced Pruritus is the main driver for Pruritus Therapeutic Market in the coming years. It is a dermatological side effect caused by some drugs.

Corticosteroids dominated the market in 2013 due to the efficiency displayed by these drugs in treating itchy skin. The high demand for chronic itching treatment is the main factor driving the market.

The lack of awareness of the cause of pruritus hampers the market growth.

North America had a major share in the market in 2013. This is due to the presence of diseases associated with Pruritus and introduction of home remedies for itching.

Growing patient awareness levels also elevate the market in the region.

For complete details: Request a sample download @ Make an Inquiry about this news

Identification of new T cell subsets and the patent expiry of drugs for treating Pruritus are bright opportunities in pruritus treatment. Manufacturers depend on R&D for developing cost effective products and preventing product recalls.

Growing prevalence of dermatological disorders enhances the growth of remedies for itchy skin.

Segmentations & Key Players Involved in the Pruritus Therapeutic Market

The Pruritus Therapeutic Market can be broken down into various segments as follows:

  • Region- Americas, APAC, and EMEA.

Some of the key players involved in the Pruritus Therapeutic Market are as follows:

  • Abbott
  • Ajanta Pharma
  • Almirall
  • Astellas Pharma
  • Bristol-Myers Squibb

Access Report @ Make an Inquiry about this news

News From

Market Intel Reports - Market Research Firm, Analysis and ForecastMarket Intel Reports
Category: Market Research Publishers and RetailersCompany about: MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers. MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufactu ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!